Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas C Turner

Showing results (11-20 of 138) with videos related to

Pageof 14
Sort By:
Cancer Cell|March 10, 2021
Understanding divergent trial results of adjuvant CDK4/6 inhibitors for early stage breast cancerNiamh C Cunningham, Nicholas C Turner
Nature Reviews. Cancer|March 18, 2017
Advances and challenges in targeting FGFR signalling in cancerIrina S Babina, Nicholas C Turner
JAMA Oncology|December 20, 2019
Clinical Benefit of Circulating Tumor DNA Analysis in Follow-up of Patients With Early-Stage Breast Cancer-ReplyIsaac Garcia-Murillas, Nicholas C Turner
BMJ (Clinical Research Ed.)|July 11, 2008
Management of breast cancer--part INicholas C Turner, Alison L Jones
The Lancet. Oncology|April 4, 2012
Genetic heterogeneity and cancer drug resistanceNicholas C Turner, Jorge S Reis-Filho
Current Opinion in Pharmacology|April 20, 2013
Tumour selective targeting of cell cycle kinases for cancer treatmentMarieke Aarts, Spiros Linardopoulos, Nicholas C Turner
The New England Journal of Medicine|February 21, 2019
Palbociclib and Fulvestrant in Breast Cancer. ReplyNicholas C Turner, Xin Huang, Massimo Cristofanilli
BMJ (Clinical Research Ed.)|June 11, 2014
An update on the medical management of breast cancerBelinda Yeo, Nicholas C Turner, Alison Jones
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 15, 2023
Managing a Long and Winding Road: Estrogen Receptor-Positive Breast CancerMichael Gnant, Nicholas C Turner, Cristina Hernando
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2013
Tackling the diversity of triple-negative breast cancerNicholas C Turner, Jorge S Reis-Filho
Pageof 14

Showing results (11-20 of 138) with videos related to

Sort By:
Pageof 14
Cancer Cell|March 10, 2021
Understanding divergent trial results of adjuvant CDK4/6 inhibitors for early stage breast cancerNiamh C Cunningham, Nicholas C Turner
Nature Reviews. Cancer|March 18, 2017
Advances and challenges in targeting FGFR signalling in cancerIrina S Babina, Nicholas C Turner
JAMA Oncology|December 20, 2019
Clinical Benefit of Circulating Tumor DNA Analysis in Follow-up of Patients With Early-Stage Breast Cancer-ReplyIsaac Garcia-Murillas, Nicholas C Turner
BMJ (Clinical Research Ed.)|July 11, 2008
Management of breast cancer--part INicholas C Turner, Alison L Jones
The Lancet. Oncology|April 4, 2012
Genetic heterogeneity and cancer drug resistanceNicholas C Turner, Jorge S Reis-Filho
Current Opinion in Pharmacology|April 20, 2013
Tumour selective targeting of cell cycle kinases for cancer treatmentMarieke Aarts, Spiros Linardopoulos, Nicholas C Turner
The New England Journal of Medicine|February 21, 2019
Palbociclib and Fulvestrant in Breast Cancer. ReplyNicholas C Turner, Xin Huang, Massimo Cristofanilli
BMJ (Clinical Research Ed.)|June 11, 2014
An update on the medical management of breast cancerBelinda Yeo, Nicholas C Turner, Alison Jones
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 15, 2023
Managing a Long and Winding Road: Estrogen Receptor-Positive Breast CancerMichael Gnant, Nicholas C Turner, Cristina Hernando
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2013
Tackling the diversity of triple-negative breast cancerNicholas C Turner, Jorge S Reis-Filho
Pageof 14